Aehr Test Draws Fresh Institutional Interest as Analysts Trim Targets Despite Record Quarter
Published on 11/16/2026 at 16:41 | Editorial boerse-global.deAehr Test Systems has caught the attention of a new institutional player just as Wall Street recalibrates its expectations for the semiconductor testing specialist. Jane Street Group, LLC disclosed economic ownership of 5.1% of the company, according to a Schedule 13G filing with the US Securities and Exchange Commission dated November 4. The filing attributes roughly 1.68 million shares to Jane Street and cites the same date as the event triggering the disclosure.
The ownership news landed alongside a pair of analyst revisions. Lake Street Capital cut its price target on Aehr to $90 from $110 on November 3, while keeping its buy rating intact. Jefferies made a similar move the same day, lowering its target to $140 from $175 without abandoning its buy recommendation either.
Record Top Line, Raised Guidance
The backdrop to those revisions is a strikingly strong quarterly report. Aehr posted revenue of $33.0 million for the first quarter of fiscal 2027 on November 2 — a record for the company and a 200% jump compared with the prior-year period. GAAP net income came in at $7.2 million, or $0.21 per diluted share.
Should investors sell immediately? Or is it worth buying Aehr Test?
Bookings for the reporting quarter reached $46.7 million, and the company put its effective backlog at $109.3 million as of November 1. Management also lifted its outlook for the full fiscal year, now projecting annual revenue of $150 million.
Trading in a Choppy Sector
The stock has not been immune to the wider mood. On Friday, Aehr shed 6.4% as technology and semiconductor shares broadly weakened. Reuters reported a wide retreat in AI-linked US equities amid renewed concerns over Nvidia and the financing of AI investments — a session in which much of the tech sector came under pressure.
The retreat in Aehr shares unfolded against that sector-wide selling, with the analyst target cuts and the Jane Street stake rounding out a busy stretch for the stock.
Ad
Aehr Test Stock: New Analysis - 16 November
Fresh Aehr Test information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
